FDA Takes “Fresh Look” At ORA Reorg, Eyes Outsourcing Some Agency Posts

FDA's decision to cancel the planned closure of seven field labs does not signal the end of efforts to reorganize the Office of Regulatory Affairs

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet